---
figid: PMC6407368__gr2
figlink: /pmc/articles/PMC6407368/figure/fig2/
number: F2
caption: Ca2+signaling pathways in β-cells. Following Ca2+ binding to Calmodulin (CaM),
  multiple downstream pathways are activated. CaM activates the Ca2+/Calmodulin-dependent
  protein kinase kinase (CaMKK) as well as members of the Ca2+/Calmodulin-dependent
  protein kinases (CaMK). Ca2+/CaM-bound CaMKK can phosphorylate and activate CaMKIV
  (A). Ca2+-bound CaM also activates the phosphatase Calcineurin (CaN) (B), which
  removes phosphate groups from CREB regulated transcription coactivator 2 (CRTC2)
  and nuclear factor of activated T cells (NFAT) proteins, resulting in their nuclear
  localization. CRTC2 can be inactivated through phosphorylation by microtubule affinity
  regulating kinase 2 (MARK2) and salt inducible kinase 2 (SIK2) (C), and NFAT can
  be inactivated by the kinases GSK3B and DYRK1A (D). Ca2+ results in the activation
  of p44/p42 (ERK1/2) or the MAP kinase pathway through the stimulation of Ras-GRF
  by CaM and the dephosphorylation of Raf by CaN (E). The NF-κB pathway can also be
  activated by Ca2+ in β-cells through the phosphorylation of IκB, which releases
  the p50 and p65 subunits (F). The upstream activation of various CaMKs and members
  of the MAP kinase pathway result in the phosphorylation and activation of cAMP response
  element binding (CREB) (G).
pmcid: PMC6407368
papertitle: 'Friend and foe: β-cell Ca2+ signaling and the development of diabetes.'
reftext: Paul V. Sabatini, et al. Mol Metab. 2019 Mar;21:1-12.
pmc_ranked_result_index: '61317'
pathway_score: 0.9594755
filename: gr2.jpg
figtitle: Ca2+signaling pathways in Beta-cells
year: '2019'
organisms:
- Homo sapiens
ndex: 4940e95e-dee1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6407368__gr2.html
  '@type': Dataset
  description: Ca2+signaling pathways in β-cells. Following Ca2+ binding to Calmodulin
    (CaM), multiple downstream pathways are activated. CaM activates the Ca2+/Calmodulin-dependent
    protein kinase kinase (CaMKK) as well as members of the Ca2+/Calmodulin-dependent
    protein kinases (CaMK). Ca2+/CaM-bound CaMKK can phosphorylate and activate CaMKIV
    (A). Ca2+-bound CaM also activates the phosphatase Calcineurin (CaN) (B), which
    removes phosphate groups from CREB regulated transcription coactivator 2 (CRTC2)
    and nuclear factor of activated T cells (NFAT) proteins, resulting in their nuclear
    localization. CRTC2 can be inactivated through phosphorylation by microtubule
    affinity regulating kinase 2 (MARK2) and salt inducible kinase 2 (SIK2) (C), and
    NFAT can be inactivated by the kinases GSK3B and DYRK1A (D). Ca2+ results in the
    activation of p44/p42 (ERK1/2) or the MAP kinase pathway through the stimulation
    of Ras-GRF by CaM and the dephosphorylation of Raf by CaN (E). The NF-κB pathway
    can also be activated by Ca2+ in β-cells through the phosphorylation of IκB, which
    releases the p50 and p65 subunits (F). The upstream activation of various CaMKs
    and members of the MAP kinase pathway result in the phosphorylation and activation
    of cAMP response element binding (CREB) (G).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DYRK1A
  - RASGRF1
  - CRTC2
  - CREB1
  - OPN1LW
  - YWHAQ
  - RASGRF2
  - SIK2
  - CREB5
  - MARK2
  - KRIT1
  - CAMK2B
  - CAMKK2
  - ATF1
  - MAP2K1
  - CREB3
  - CREB3L4
  - ARAF
  - RAF1
  - BRAF
  - HRAS
  - GSK3B
  - NRAS
  - CREB3L2
  - MAP2K2
  - ATF2
  - CREM
  - NFAT5
  - CREB3L3
  - CREB3L1
  - NFATC4
  - NFATC1
  - NFATC2
  - KRAS
  - NFATC3
  - Ca2+
  - CaN
  - GDP
  - F
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: DYRK1A
  symbol: DYRK1A
  source: hgnc_symbol
  hgnc_symbol: DYRK1A
  entrez: '1859'
- word: Ras-GRF
  symbol: RASGRF
  source: bioentities_symbol
  hgnc_symbol: RASGRF1
  entrez: '5923'
- word: CRTC2
  symbol: CRTC2
  source: hgnc_symbol
  hgnc_symbol: CRTC2
  entrez: '200186'
- word: CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CBP
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: 14-3-3
  symbol: 14-3-3
  source: hgnc_alias_symbol
  hgnc_symbol: YWHAQ
  entrez: '10971'
- word: Ras-GRF
  symbol: RASGRF
  source: bioentities_symbol
  hgnc_symbol: RASGRF2
  entrez: '5924'
- word: SIK2
  symbol: SIK2
  source: hgnc_symbol
  hgnc_symbol: SIK2
  entrez: '23235'
- word: CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: MARK2
  symbol: MARK2
  source: hgnc_symbol
  hgnc_symbol: MARK2
  entrez: '2011'
- word: CaM
  symbol: CAM
  source: hgnc_alias_symbol
  hgnc_symbol: KRIT1
  entrez: '889'
- word: CAMKII
  symbol: CAMK2
  source: hgnc_alias_symbol
  hgnc_symbol: CAMK2B
  entrez: '816'
- word: CAMKK
  symbol: CAMKK
  source: hgnc_alias_symbol
  hgnc_symbol: CAMKK2
  entrez: '10645'
- word: CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
chemicals:
- word: Ca2+
  source: MESH
  identifier: D002118
- word: CaN
  source: MESH
  identifier: D002118
- word: GDP
  source: MESH
  identifier: D006153
- word: F
  source: MESH
  identifier: D005461
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6407368__F2
redirect_from: /figures/PMC6407368__F2
figtype: Figure
---
